166 related articles for article (PubMed ID: 38650040)
21. Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features.
Lucas CG; Villanueva-Meyer JE; Whipple N; Oberheim Bush NA; Cooney T; Chang S; McDermott M; Berger M; Cham E; Sun PP; Putnam A; Zhou H; Bollo R; Cheshier S; Poppe MM; Fung KM; Sung S; Glenn C; Fan X; Bannykh S; Hu J; Danielpour M; Li R; Alva E; Johnston J; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Pekmezci M; Tihan T; Bollen AW; Perry A; Solomon DA
Brain Pathol; 2020 May; 30(3):479-494. PubMed ID: 31609499
[TBL] [Abstract][Full Text] [Related]
22. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma.
International Cancer Genome Consortium PedBrain Tumor Project
Nat Med; 2016 Nov; 22(11):1314-1320. PubMed ID: 27748748
[TBL] [Abstract][Full Text] [Related]
23. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy].
Qi XL; Yao K; Duan ZJ; Bian Y; Ma Z; Piao YS; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2018 Sep; 47(9):664-670. PubMed ID: 30220118
[No Abstract] [Full Text] [Related]
24. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.
Bao ZS; Chen HM; Yang MY; Zhang CB; Yu K; Ye WL; Hu BQ; Yan W; Zhang W; Akers J; Ramakrishnan V; Li J; Carter B; Liu YW; Hu HM; Wang Z; Li MY; Yao K; Qiu XG; Kang CS; You YP; Fan XL; Song WS; Li RQ; Su XD; Chen CC; Jiang T
Genome Res; 2014 Nov; 24(11):1765-73. PubMed ID: 25135958
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
[TBL] [Abstract][Full Text] [Related]
26. Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas.
Benhamida JK; Harmsen HJ; Ma D; William CM; Li BK; Villafania L; Sukhadia P; Mullaney KA; Dewan MC; Vakiani E; Karajannis MA; Snuderl M; Zagzag D; Ladanyi M; Rosenblum MK; Bale TA
Brain Pathol; 2023 Sep; 33(5):e13185. PubMed ID: 37399073
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma.
Nakano Y; Tomiyama A; Kohno T; Yoshida A; Yamasaki K; Ozawa T; Fukuoka K; Fukushima H; Inoue T; Hara J; Sakamoto H; Ichimura K
Brain Tumor Pathol; 2019 Jan; 36(1):14-19. PubMed ID: 30350109
[TBL] [Abstract][Full Text] [Related]
28. Integrated genetic profiling of archival pediatric high-grade glial tumors and reassessment with 2021 WHO classification of paediatric CNS tumours.
Cooley LD; Lansdon LA; Laurence K; Herriges JC; Zhang L; Repnikova EA; Joyce J; Thakor P; Warren L; Smith SC; Yoo B; Gener M; Ginn KF; Farooqi MS
Cancer Genet; 2023 Jun; 274-275():10-20. PubMed ID: 36917897
[TBL] [Abstract][Full Text] [Related]
29. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
[TBL] [Abstract][Full Text] [Related]
30. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
[TBL] [Abstract][Full Text] [Related]
31. Uncommon Glioneuronal Tumors: A Radiologic and Pathologic Synopsis.
Vaz A; Cavalcanti MS; da Silva Junior EB; Ramina R; de Almeida Teixeira BC
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1080-1089. PubMed ID: 35512827
[TBL] [Abstract][Full Text] [Related]
32.
Jones KA; Bossler AD; Bellizzi AM; Snow AN
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936198
[TBL] [Abstract][Full Text] [Related]
33. Rare variant of large pediatric glioneuronal tumor with novel MYO5A::NTRK3 fusion: illustrative case.
Chenoweth D; Syed H; Teferi N; Challa M; Persons JE; Eschbacher KL; Seblani M; Dlouhy BJ
J Neurosurg Case Lessons; 2024 Mar; 7(10):. PubMed ID: 38437672
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytoma.
Tauziède-Espariat A; Beccaria K; Dangouloff-Ros V; Sievers P; Meurgey A; Pissaloux D; Appay R; Saffroy R; Grill J; Mariet C; Bourdeaut F; Hasty L; Métais A; Chrétien F; Blauwblomme T; Puget S; Boddaert N; Varlet P;
Brain Pathol; 2023 Sep; 33(5):e13182. PubMed ID: 37349135
[TBL] [Abstract][Full Text] [Related]
35. BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.
Dimitriadis E; Alexiou GA; Tsotsou P; Simeonidi E; Stefanaki K; Patereli A; Prodromou N; Pandis N
J Neurooncol; 2013 Jul; 113(3):353-8. PubMed ID: 23612919
[TBL] [Abstract][Full Text] [Related]
36. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic Features of Diencephalic Neuronal and Glioneuronal Tumors.
Ho CY; Bornhorst M; Almira-Suarez MI; Donev K; Grafe M; Gordish-Dressman H; Rodriguez FJ
J Neuropathol Exp Neurol; 2020 Jan; 79(1):67-73. PubMed ID: 31793986
[TBL] [Abstract][Full Text] [Related]
38. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
40. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors.
Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Choi KS; Park JE; Ahn SS; Chang JH; Kim SH
J Magn Reson Imaging; 2023 Dec; 58(6):1680-1702. PubMed ID: 37715567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
